PubMed

Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?

Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH.

Br J Ophthalmol. 2004 Aug;88(8):1069-73.PMID: 15258027 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.

Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.

Ophthalmology. 2007 Nov;114(11):2083-9. Epub 2007 Apr 24.PMID: 17459482 [PubMed - indexed for MEDLINE]Related articles

Results of a prospective study for the treatment of retinoblastoma.

Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.

Cancer. 2004 Feb 15;100(4):834-42.PMID: 14770442 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.

Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.

Pediatr Blood Cancer. 2007 Sep;49(3):256-60.PMID: 17029248 [PubMed - indexed for MEDLINE]Related articles

Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.

Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.

Arch Ophthalmol. 2001 Jan;119(1):41-8.PMID: 11146725 [PubMed - indexed for MEDLINE]Related articles

Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.

Cuenca A, Giron F, Castro D, Fandiño A, Guitter M, de Dávila MT, Chantada G.

Arch Ophthalmol. 2009 Aug;127(8):1006-10.PMID: 19667337 [PubMed - indexed for MEDLINE]Related articles

Postenucleation adjuvant therapy in high-risk retinoblastoma.

Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, Shields JA.

Arch Ophthalmol. 2002 Jul;120(7):923-31.PMID: 12096963 [PubMed - indexed for MEDLINE]Related articles

Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.

Mustafa MM, Jamshed A, Khafaga Y, Mourad WA, Al-Mesfer S, Kofide A, El-Husseiny G, Gray A.

J Pediatr Hematol Oncol. 1999 Sep-Oct;21(5):364-9.PMID: 10524448 [PubMed - indexed for MEDLINE]Related articles

Retinoblastoma with low risk for extraocular relapse.

Chantada GL, de Dávila MT, Fandiño A, Manzitti J, Raslawski E, Casak S, Schvartzman E.

Ophthalmic Genet. 1999 Sep;20(3):133-40.PMID: 10520234 [PubMed - indexed for MEDLINE]Related articles

Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.

Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL, Erwenne CM.

Br J Ophthalmol. 2003 Oct;87(10):1224-8.PMID: 14507753 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.

Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT.

Ophthalmology. 1997 Dec;104(12):2101-11.PMID: 9400771 [PubMed - indexed for MEDLINE]Related articles

Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.

Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P.

Arch Pathol Lab Med. 2006 Nov;130(11):1669-72.PMID: 17076529 [PubMed - indexed for MEDLINE]Related articles

Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.

Bellaton E, Bertozzi AI, Behar C, Chastagner P, Brisse H, Sainte-Rose C, Doz F, Desjardins L.

Br J Ophthalmol. 2003 Mar;87(3):327-9.PMID: 12598448 [PubMed - indexed for MEDLINE]Related articlesFree article

First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.

Beck MN, Balmer A, Dessing C, Pica A, Munier F.

J Clin Oncol. 2000 Aug;18(15):2881-7.PMID: 10920136 [PubMed - indexed for MEDLINE]Related articles

Vitrectomy in eyes with unsuspected retinoblastoma.

Shields CL, Honavar S, Shields JA, Demirci H, Meadows AT.

Ophthalmology. 2000 Dec;107(12):2250-5.PMID: 11097606 [PubMed - indexed for MEDLINE]Related articles

Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.

Khelfaoui F, Validire P, Auperin A, Quintana E, Michon J, Pacquement H, Desjardins L, Asselain B, Schlienger P, Vielh P, et al.

Cancer. 1996 Mar 15;77(6):1206-13.PMID: 8635145 [PubMed - indexed for MEDLINE]Related articles

Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.

Ophthalmology. 2004 Oct;111(10):1917-24.PMID: 15465557 [PubMed - indexed for MEDLINE]Related articles

Treatment of overt extraocular retinoblastoma.

Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.

Med Pediatr Oncol. 2003 Mar;40(3):158-61.PMID: 12518344 [PubMed - indexed for MEDLINE]Related articles

World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.

Chantada GL, Doz F, Orjuela M, Qaddoumi I, Sitorus RS, Kepak T, Furmanchuk A, Castellanos M, Sharma T, Chevez-Barrios P, Rodriguez-Galindo C; International Retinoblastoma Staging Working Group.

Pediatr Blood Cancer. 2008 Mar;50(3):692-4.PMID: 18059037 [PubMed - indexed for MEDLINE]Related articles

Intraocular retinoblastoma group V: an analysis of prognostic factors.

Rubin CM, Robison LL, Cameron JD, Woods WG, Nesbit ME Jr, Krivit W, Kim TH, Letson RD, Ramsay NK.

J Clin Oncol. 1985 May;3(5):680-5.PMID: 3998784 [PubMed - indexed for MEDLINE]Related articles